Xpectra 200mg Tablet contains Faropenem, a broad-spectrum oral carbapenem antibiotic effective against a wide range of Gram-positive and Gram-negative bacterial infections. It is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other bacterial infections caused by susceptible organisms. Faropenem exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The 200mg dosage provides an optimal balance between efficacy and safety for adult patients. Xpectra is particularly useful in cases where resistance to other beta-lactam antibiotics is a concern. It is generally well-tolerated, with adverse effects being mild and infrequent; common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Caution is advised in patients with a history of hypersensitivity to beta-lactam antibiotics. Dosage adjustments may be necessary in patients with renal impairment. Xpectra should be administered as prescribed by a healthcare professional, and the full course of therapy should be completed to prevent the development of antibiotic resistance. It is contraindicated in patients with known hypersensitivity to Faropenem or any component of the formulation.